OMNY-AF | Cleveland Clinic
You may be interested in taking part in this study if you have been diagnosed with symptomatic Paroxysmal Atrial Fibrillation (PAF), a type of atrial fibrillation where irregular and rapid …
Johnson & Johnson MedTech Completes Pilot Phase Enrollment of OMNY-AF …
2024年10月30日 · OMNY-AF is a prospective, single-arm, multi-center clinical trial that has completed the pilot phase enrollment of 30 patients and will enroll up to 410 additional patients …
Johnson & Johnson MedTech Completes Pilot Phase Enrollment of OMNY-AF …
2024年10月30日 · Johnson & Johnson MedTech, a global leader in cardiac arrhythmia treatment, announced the enrollment completion of the pilot phase of the OMNY-AF clinical trial, a study …
OMNY-AF | Northwell Health
The purpose of this study is to demonstrate the safety and 12-month effectiveness of the BWI OMNYPULSE™ pulsed field ablation (PFA) platform for pulmonary vein isolation (PVI) in the …
OMNY-AF | Minneapolis Heart Institute Foundation
Diagnosed with symptomatic paroxysmal AF with: AF secondary to electrolyte imbalance, thyroid disease, or reversible or non-cardiac cause. Patients known to require ablation outside the PV …
Johnson & Johnson completes pilot enrollment in Omnypulse trial
2024年10月30日 · Johnson & Johnson MedTech today announced the completed enrollment in the pilot phase of a clinical trial for its Omnypulse pulsed field ablation platform. The OMNY-AF …
Johnson & Johnson MedTech concludes enrolment for OMNY-AF
2024年11月1日 · Johnson & Johnson MedTech has concluded subject enrolment for the pilot phase of the OMNY-AF study of the investigational OMNYPULSE Platform for treating …
Johnson & Johnson MedTech Completes Pilot Phase Enrollment …
2024年10月30日 · This study is evaluating the investigational OMNYPULSE™ Platform for treating symptomatic paroxysmal atrial fibrillation (AFib) in the United States and Australia. …
Johnson & Johnson MedTech Completes Pilot Phase Enrollment of OMNY-AF …
2024年10月30日 · The OMNY-AF study is a prospective, single-arm, multi-center study evaluating the clinical safety and effectiveness of the OMNYPULSE™ Catheter for the treatment of …
Johnson & Johnson MedTech finalises pilot phase enrollment of OMNY-AF …
2024年11月4日 · Johnson & Johnson MedTech, which is a global leader in cardiac arrhythmia treatment, announced the enrollment completion of the pilot phase of the OMNY-AF clinical …